Lilly PACKAGE LABEL - Zepbound Multi-Dose Vial - 15 mg/0.6 mL Dose (60 mg/2.4 mL [25 mg/mL]) Rx Only NDC 0002-6612-11 Zepbound (tirzepatide) injection 60 mg/2.4 mL (25 mg/mL) ATTENTION: Contains 4 doses of 15 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
In a preclinical model, selective GIP agonist administration resulted in marked improvement of lipoprotein profile, suggesting that the GIP component may be an important contributor to metabolic improvements of GIP and GLP-1 receptor agonists, like tirzepatide [57]
Because the liposome is made of the same material as your cells, it can fuse more easily with the lining of the small intestine
When a drug is listed on the FDAs drug shortage list, licensed compounders are often allowed to create versions of the medication, making them more accessible to patients who cannot obtain the brand-name drug
When gastric emptying is delayed, food remains in the stomach and upper digestive tract for longer periods
10.1016/j.tjnut.2023.12.051 J Nutr